Puma Biotechnology, Inc.PBYINASDAQ
Loading
Revenue Growth Recovery in ProgressRecovering
Percentile Rank21
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P21
Within normal range
vs 2Y Ago
-0.3x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-0.91%
2024-2.19%
20233.34%
2022-9.92%
202112.46%
2020-17.32%
20198.47%
2018806.14%
20170.00%
20160.00%